These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 19464572)
21. Characterization of Variability in Toxicokinetics and Toxicodynamics of Tetrachloroethylene Using the Collaborative Cross Mouse Population. Cichocki JA; Furuya S; Venkatratnam A; McDonald TJ; Knap AH; Wade T; Sweet S; Chiu WA; Threadgill DW; Rusyn I Environ Health Perspect; 2017 May; 125(5):057006. PubMed ID: 28572074 [TBL] [Abstract][Full Text] [Related]
22. Plasma binding of trichloroacetic acid in mice, rats, and humans under cancer bioassay and environmental exposure conditions. Lumpkin MH; Bruckner JV; Campbell JL; Dallas CE; White CA; Fisher JW Drug Metab Dispos; 2003 Oct; 31(10):1203-7. PubMed ID: 12975328 [TBL] [Abstract][Full Text] [Related]
23. Workers' breath as a source of perchloroethylene (Perc) in the home. Thompson KM; Evans JS J Expo Anal Environ Epidemiol; 1993; 3(4):417-30. PubMed ID: 8173342 [TBL] [Abstract][Full Text] [Related]
24. Acute perchloroethylene exposure alters rat visual-evoked potentials in relation to brain concentrations. Boyes WK; Bercegeay M; Oshiro WM; Krantz QT; Kenyon EM; Bushnell PJ; Benignus VA Toxicol Sci; 2009 Mar; 108(1):159-72. PubMed ID: 19098276 [TBL] [Abstract][Full Text] [Related]
25. Early lifestage exposure and potential developmental susceptibility to tetrachloroethylene. Brown Dzubow R; Makris S; Siegel Scott C; Barone S Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):50-65. PubMed ID: 20041493 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Abbas RR; Seckel CS; Kidney JK; Fisher JW Drug Metab Dispos; 1996 Dec; 24(12):1340-6. PubMed ID: 8971140 [TBL] [Abstract][Full Text] [Related]
27. Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice. Cichocki JA; Furuya S; Konganti K; Luo YS; McDonald TJ; Iwata Y; Chiu WA; Threadgill DW; Pogribny IP; Rusyn I J Pharmacol Exp Ther; 2017 Apr; 361(1):17-28. PubMed ID: 28148637 [TBL] [Abstract][Full Text] [Related]
28. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Stauber AJ; Bull RJ Toxicol Appl Pharmacol; 1997 Jun; 144(2):235-46. PubMed ID: 9194407 [TBL] [Abstract][Full Text] [Related]
29. Kinetics of trichloroacetic acid and dichloroacetic acid in the isolated perfused rat liver. Toxopeus C; Frazier JM Toxicol Appl Pharmacol; 1998 Sep; 152(1):90-8. PubMed ID: 9772204 [TBL] [Abstract][Full Text] [Related]
30. Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2008; 27 Suppl 2():25-39. PubMed ID: 18830862 [TBL] [Abstract][Full Text] [Related]
31. Environmental risk assessment of airborne trichloroacetic acid--a contribution to the discussion on the significance of anthropogenic and natural sources. Ahlers J; Regelmann J; Riedhammer C Chemosphere; 2003 Jul; 52(2):531-7. PubMed ID: 12738278 [TBL] [Abstract][Full Text] [Related]
32. Effect of perchloroethylene and its metabolites on intercellular communication in clone 9 rat liver cells. Benane SG; Blackman CF; House DE J Toxicol Environ Health; 1996 Aug; 48(5):427-37. PubMed ID: 8751833 [TBL] [Abstract][Full Text] [Related]
33. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene. Nong A; McCarver DG; Hines RN; Krishnan K Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene. Clewell HJ; Gentry PR; Kester JE; Andersen ME Crit Rev Toxicol; 2005 Jun; 35(5):413-33. PubMed ID: 16097137 [TBL] [Abstract][Full Text] [Related]
35. Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies. Chiu WA; Micallef S; Monster AC; Bois FY Toxicol Sci; 2007 Jan; 95(1):23-36. PubMed ID: 17032701 [TBL] [Abstract][Full Text] [Related]
36. On the importance of exposure variability to the doses of volatile organic compounds. Rappaport SM; Kupper LL; Lin YS Toxicol Sci; 2005 Feb; 83(2):224-36. PubMed ID: 15548640 [TBL] [Abstract][Full Text] [Related]
37. Inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice. Charest-Tardif G; Tardif R; Krishnan K Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):63-9. PubMed ID: 16085205 [TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity on chromosome 6 in dichloroacetic acid and trichloroacetic acid-induced liver tumors in female B6C3F1 mice. Tao L; Li K; Kramer PM; Pereira MA Cancer Lett; 1996 Nov; 108(2):257-61. PubMed ID: 8973603 [TBL] [Abstract][Full Text] [Related]
39. The application of physiologically based pharmacokinetic modelling in the analysis of occupational exposure to perchloroethylene. Loizou GD Toxicol Lett; 2001 Oct; 124(1-3):59-69. PubMed ID: 11684358 [TBL] [Abstract][Full Text] [Related]
40. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME Toxicol Appl Pharmacol; 1990 Mar; 102(3):497-513. PubMed ID: 2315918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]